SARRP used in Combination Therapy Tumor Suppression

September 21, 2021

The below graphic displays highlights from the study, “Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models” by HJ Yun, HJ Kim, J Kim, SY Kim, HS Chang, CS Park, HJ Chang, and KC Park.

See more below and the full article here.

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts